Related references
Note: Only part of the references are listed.AChE mRNA expression as a possible novel biomarker for the diagnosis of coronary artery disease and Alzheimer's disease, and its association with oxidative stress
Mesut Isik et al.
ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY (2022)
Oxidative Stress and Changes of Important Metabolic Gene Expressions as a Potential Biomarker in the Diagnosis of Atherosclerosis in Leukocytes
Mesut Isik et al.
BRAZILIAN JOURNAL OF CARDIOVASCULAR SURGERY (2022)
Plasma GSH levels and Alzheimer's disease. A prospective approach.: Results from the HELIAD study
S. Charisis et al.
FREE RADICAL BIOLOGY AND MEDICINE (2021)
Methylglyoxal affects cognitive behaviour and modulates RAGE and Presenilin-1 expression in hippocampus of aged mice
M. Pucci et al.
FOOD AND CHEMICAL TOXICOLOGY (2021)
Connection between the Altered HDL Antioxidant and Anti-Inflammatory Properties and the Risk to Develop Alzheimer's Disease: A Narrative Review
Francesca Zimetti et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2021)
Arylesterase Activity of Paraoxonase-1 in Serum and Cerebrospinal Fluid of Patients with Alzheimer's Disease and Vascular Dementia
Arianna Romani et al.
ANTIOXIDANTS (2020)
Evaluating the link between Paraoxonase-1 levels and Alzheimer's disease development
Carlo Cervellati et al.
MINERVA MEDICA (2019)
Role of Catalase in Oxidative Stress- and Age-Associated Degenerative Diseases
Ankita Nandi et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2019)
A systemic view of Alzheimer disease - insights from amyloid-β metabolism beyond the brain
Jun Wang et al.
NATURE REVIEWS NEUROLOGY (2017)
Neuroprotective mechanisms of plant extracts against MPTP induced neurotoxicity: Future applications in Parkinson's disease
Abdelrahman Ibrahim Abushouk et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Function and toxicity of amyloid beta and recent therapeutic interventions targeting amyloid beta in Alzheimer's disease
K. Rajasekhar et al.
CHEMICAL COMMUNICATIONS (2015)
PON-1 and ferroxidase activities in older patients with mild cognitive impairment, late onset Alzheimer's disease or vascular dementia
Carlo Cervellati et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2015)
Association between paraoxonase gene and stroke in the Han Chinese population
Guojun Zhang et al.
BMC MEDICAL GENETICS (2013)
Paraoxonase 1 (PON1) as a genetic determinant of susceptibility to organophosphate toxicity
Lucio G. Costa et al.
TOXICOLOGY (2013)
The Economic Analysis of Prevention in Mental Health Programs
Cathrine Mihalopoulos et al.
ANNUAL REVIEW OF CLINICAL PSYCHOLOGY (2011)
A Step Further Towards Multitarget Drugs for Alzheimer and Neuronal Vascular Diseases: Targeting the Cholinergic System, Amyloid-β Aggregation and Ca2+ Dyshomeostasis
R. Leon et al.
CURRENT MEDICINAL CHEMISTRY (2011)
Inhibitors of Catalase-Amyloid Interactions Protect Cells from β-Amyloid-Induced Oxidative Stress and Toxicity
Lila K. Habib et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Changes of some oxidative stress markers in the serum of patients with mild cognitive impairment and Alzheimer's disease
Manuela Padurariu et al.
NEUROSCIENCE LETTERS (2010)
The paraoxonases: role in human diseases and methodological difficulties in measurement
Jordi Camps et al.
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2009)
Neuropathology and Cognitive Impairment in Alzheimer Disease: A Complex but Coherent Relationship
Peter T. Nelson et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2009)
Catalase Deficiency and Type 2 Diabetes
L. Goth
DIABETES CARE (2008)
Restoration of peroxisomal catalase import in a model of human cellular aging
Jay I. Koepke et al.
TRAFFIC (2007)
Tandem purification of two HDL-associated partner proteins in human plasma, paraoxonase (PON1) and phosphate binding protein (HPBP) using hydroxyapatite chromatography
Frederique Renault et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2006)
Cholesterol in Alzheimer's disease
LA Shobab et al.
LANCET NEUROLOGY (2005)
A new type 1 diabetes susceptibitity locus containing the catalase gene (chromosome 11p13) in a Russian population
DA Chistiakov et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2004)
Retardation of atherosclerosis by overexpression of catalase or both Cu/Zn-superoxide dismutase and catalase in mice lacking apolipoprotein E
H Yang et al.
CIRCULATION RESEARCH (2004)
Oxidative damage is the earliest event in Alzheimer disease
A Nunomura et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2001)
Active glycation in neurofibrillary pathology of Alzheimer disease:: Nε-(carboxymethyl) lysine and hexitol-lysine
RJ Castellani et al.
FREE RADICAL BIOLOGY AND MEDICINE (2001)
A new mathematical model for relative quantification in real-time RT-PCR
MW Pfaffl
NUCLEIC ACIDS RESEARCH (2001)
Changes in thiol content and expression of glutathione redox system genes in the hippocampus and cerebellum in Alzheimer's disease
MY Aksenov et al.
NEUROSCIENCE LETTERS (2001)
Combined serum paraoxonase knockout/apolipoprotein E knockout mice exhibit increased lipoprotein oxidation and atherosclerosis
DM Shih et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
